The system integrates the molecular imaging capabilities of PET with the soft-tissue contrast of MRI to image disease cells as they proliferate in soft tissue. The first system is installed at the University Hospital of Geneva in Switzerland.
Philips anticipates that clinicians will use Ingenuity TF PET/MRI to examine patients at high risk for heart disease to treat diseased cells prior to the formation of dangerous coronary plaques. The system may also be used to scan patients to detect tumor formation and recurrence.
Ingenuity TF is pending 510(k) clearance by the U.S. Food and Drug Administration (FDA).
Philips' healthcare sales edge higher in Q4, January 24, 2011
Philips hits DigitalDiagnost milestone, December 23, 2010
Philips initiates magnetic particle imaging effort, December 21, 2010
Philips launches Ingenia MRI line, CT scanner at RSNA show, November 29, 2010
Philips wins Fla. x-ray install, November 4, 2010
Copyright © 2011 AuntMinnie.com